Delivering pharmaceuticals safely

Upcoming events:

Extractables and Leachables USA 2014

With over 18 expert speakers from companies such as Boehringer Ingelheim, NovoNordisk, Baxter and more, plus an opening address from Dr Ingrid Markovic of the FDA, ensuring that you are up to date with the regulatory viewpoint surrounding extractables and leachables and a sold out exhibition, E&L USA is not to be missed if you are involved with the safety of medical devices and pharmaceutical packaging. Take a look at the full program >>

Smithers Rapra E&L USA 2014 conference is coming to the Sheraton Silver Spring, MD on May 7-9.

The E&L USA 2014 conference brochure is now available to download, get your free copy now >>

Smithers Rapra's E&L events are going from strength to strength and there is no better time to get involved and find out how you can ensure best practise in your business and hear about all the latest regulatory guidance and testing techniques.

New to the world of extractables and leachables?
Don't miss our introductory pre-conference seminar, which will teach you the first principles of E&L testing and bring you up to speed with the intermediate knowledge to build on during the main conference. Take a look at the workshop details here >>

Find out more about Extractable and Leachables USA conference >>

Poster sessions confirmed >>

Extractables and Leachables Europe 2014

Smithers Rapra is pleased to announce the 8th annual Extractables and Leachables European conference has been confirmed. Due to the huge success and growth E&L Europe has had over the last couple of years, the conference this year is proud to stand alone, with even more dedicated networking time in a dedicated environment.

Extractables and Leachables Europe 2014 will be coming to Barcelona on 11-12 November 2014 at the Novotel Barcelona City, Spain.

Book your place to attend the 2014 Extractables and Leachables two day conference >>

To stay connected and hear all of the latest E&L news connect with SmithersRapraELon Twitter >>

Past events:

E&L USA 2013

Run by Smithers Rapra, in Providence, RI in May 2013, the US forum provided delegates with the opportunity to come together to discuss all of the current E&L issues facing the pharmaceutical industry.

With 100% postitive delegate feedback and more than half of attendees expecting to generate new business from the conference, this event was a great success with a huge audience beating last yea'rs record attendance.

This inaugural event featured a high profile line up of speakers from working groups IPAC-RS, PQRI, ELSIE and industry leaders Boehringer Ingelheim, Eli Lilly, NovoNordisk, and many more!

speaking companies

See more about E&L USA >>

E&L Europe 2013

eandlWith the largest audience to date the 2013 Extractables and Leachables Europe was one of the biggest and best conferences to date. With attendees providing great feedback...

- 100% will definitely or are likely to attend again
- 100% rated the overall conference experience as excellent or above average
- 98% said the speakers were excellent or above average
- 98% found the content was excellent or above average

On 10-11 December, the conference programme featured a comprehensive representation of best practice examples in pharmaceutical packaging, as well as the latest regulatory and working group updates, analytical chemist perspectives, and technical innovations from top pharmaceutical companies and materials suppliers.

Not only did delegates hear from many top speakers including experts from GlaxoSmithKline, Borealis Group, Baxter Innovations and more, they also had the chance to network with industry peers and potential clients throughout their time in London.

See who you missed in London >>

Conference proceedings

The conference proceedings will be available for purchase through the Smithers Rapra website, 8 weeks after the conference. They contain the papers presented by speakers over the two-day event.

Supporting Partner

Medical News Banner

Sponsor or exhibit at E&L USA 2014 Arrows

Sponsoring or exhibiting at this event is a great opportunity to showcase your products and services to key players and decision makers from your industry and to ensure your name is firmly positioned at the forefront of E&L activity. Click here for details of how to raise your company’s profile and build brand awareness...view document

Stay up to date with industry developments on Linked In Arrows

Stay up to date with industry developments on Linked In

Join the Smithers Rapra Extractables and Leachables LinkedIn group to share and discuss ideas about the analysis of extractables and leachables in medical devices...view link

E&L Europe Key Speakers

Dennis Jenke
Baxter Healthcare Corp

Dr. Dennis Jenke is a Baxter Distinguished Scientist in the Technology Resources Division of the Baxter Healthcare Corporation. In this role, he works with a team of analytical chemistry professionals whose primary responsibility includes the development, validation and application of diverse analytical strategies and methods for the discovery, identification and quantification of trace constituents in pharmaceutically relevant solutions and samples.

Dennis Jenke
Mike Hodgson
Glaxo Smith Kline

After graduating as an Analytical Chemist in 2001, Mike commenced a PhD in flavour chemistry at the University of Nottingham studying the physiological and physicochemical factors affecting the delivery of aroma compounds to the nasal receptors. This research involved the development and validation of novel analytical methods to monitor the real time delivery of aroma to the nasal cavity as model food systems were consumed. On completion of his PhD in 2004, Mike joined the Extractable/Leachable team at GSK as an analytical chemist. In this varied role, Mike utilised his prior analytical chemistry knowledge to develop and validate trace analysis methods to quantify substances that have either leached, or been extracted, from materials used to manufacture, deliver or package GSK pharmaceuticals. Between 2008 and 2011, Mike took up a position within the Inhalation and Devices Centre of Emphasis (IDCOE) at Pfizer to support the development of a Dry Powder Inhalation device ensuring the toxicological risks associated with the materials used were minimal. In Sept 2001, Mike moved back to GSK to continue his involvement in E&L supporting a range of projects from a technical perspective, implementing novel sample preparation technologies and evolving the analytical methodology in the team to ensure alignment with new types of pharmaceuticals within the pipeline. Since 2008, Mike has been an active member of the IPAC-RS Materials group working on numerous initiatives, such as supplier interactions, baseline requirements for materials and more recently risk assessment tools.

Mike Hodgson
Gerry McAuley
BioPhorum Operations Group

Gerry is a BioPhorum Operations Group (BPOG) facilitator supporting BPOG Extractables & Leachables team. He is an experienced management consultant who has worked in different sectors with blue chip clients on Lean and other change assignments, both in the UK and internationally. Although his background is largely in FMCG and service industries with companies such as Unilever and Serco, he has had experience of the Pharmaceutical and Biotech industries over the years working with Reckitt Benckiser Healthcare, Medeva and Eden Biodesign (part of the Watson Group).

Gerry McAuley
Delphine Brissaud
Becton Dickinson

Delphine Brissaud is a Senior Scientist at BD Medical Pharmaceutical Systems with over a decade of experience focused on extractables and leachables in prefillable syringes. Her main responsibility has been supporting R&D projects as well as current business on extractable studies. This included definition of extraction parameters, development and validation of analytical methods and supervision of laboratory technicians. She holds a degree in chemistry from Clermont-Ferrand School of Chemistry (ENSCCF – France) and a specialization in drug/packaging interactions from the Faculty of Pharmacy of Paris (France).

Delphine Brissaud
Thilde Marboe
Ferring Pharmaceuticals AS

Thilde Marboe graduated as MSc. in Food Science and Technology from the Royal Veterinary and Agricultural University of Copenhagen in 2006 and joined Novo Nordisk A/S as a Packaging Development Engineer where she worked until 2009 where she joined Ferring Pharmaceuticals A/S, Global Pharmaceutical R&D, Medical Devices & Packaging in a Reasearch Scientist position. Thilde has experience within the field of container closure system/drug device combination producs for pharmaceutical product and works with development/selection, functional testing, design of extractables and leachables test programmes and regulatory evaluations within this field.

Thilde Marboe
Reinhard Stidl
Baxter Innovations GmbH

Dr. Reinhard Stidl, Baxter Innovations GmbH; Vienna, Austria. Reinhard Stidl is a chemist and toxicologist by training and Senior Scientist at Baxter Innovations GmbH leading the Toxicological Risk Assessment group. Since 2007 he is responisible for the safety assessment of impurities, excipients, chemical modifications of APIs, as well as specification limits based on safety data for parenteral drug products. The toxicological evaluation of Extractables and leachables has become a major focus in the last years.

Reinhard Stidl
Stay in touch

Sign up to receive further information and event updates.

Sponsors and Exhibitors
  • Aspen Research Corporation
  • bibra toxicology advice & consulting
  • Cenveo Labels & Packaging
  • Chemic Laboratories, Inc.
  • Eurofins - Lancaster Labs
  • GERSTEL, Inc.
  • NSF Health Sciences
  • PPD
  • SGS Life Science Services
  • Smithers Avanza
  • Smithers Rapra
  • Sun Chemical
  • Thermo Scientific
  • Toxikon Corporation
  • West Pharmaceutical Services
Media Partners
  • Medical Plastics News
  • PharmaVOICE
  • Eurasian Chemical Market
  • ONdrugDelivery